Population aging is predicted to be the primary contributor to the estimated 112% surge in global Parkinson's disease cases by 2050, a BMJ study finds.
New research emphasizes early detection of underlying neurologic conditions can improve outcomes for patients presenting with lower urinary tract symptoms
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
February's FDA approvals feature advancements in cardiology, neurology, infectious diseases, and rare disorders, including the first trials for genetically modified pig kidney transplants and novel treatments for Parkinson’s disease and spinal muscular atrophy.
Anticholinergic bladder drugs were associated with an increased risk of dementia compared with nonuse, but not when compared with the beta-3 agonist mirabegron.